Cancer: The blind spot of p53

Nature

Volumn 468, Issue 7323, 2010, Pages 519-520

  Berns, Anton ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN P53; TAMOXIFEN;

ASSAY; CANCER; CELL ORGANELLE; DEVELOPMENTAL BIOLOGY; DISEASE PREVALENCE; GENETIC ANALYSIS; GENETIC MARKER; TUMOR;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER MODEL; CANCER RESEARCH; CANCER SURVIVAL; CARCINOGENESIS; CELL AGING; CELL DEATH; DNA DAMAGE; DRUG RESPONSE; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GENETIC RECOMBINATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; TUMOR CELL;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; NEOPLASMS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78649466451     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/468519a     Document Type: Short Survey

References (9)

1. Feldser, D. M. et al. Nature 468, 572-575 (2010).
2. Junttila, M. R. et al. Nature 468, 567-571 (2010).
3. Martins, C. P., Brown-Swigart, L. & Evan, G. I. Cell 127, 1323-1334 (2006).
4. Ventura, A. et al. Nature 445, 661-665 (2007).
5. Xue, W. et al. Nature 445, 656-660 (2007).
6. Christophorou, M. A., Ringshausen, I., Finch A. J., Brown Swigart, L. & Evan, G. I. Nature 443, 214-217 (2006).
7. Moore, L. et al. Oncogene 22, 7831-7837 (2003).
8. Sherr, C. J. Nature Rev. Cancer 6, 663-673 (2006).
9. Meek, D. W. Nature Rev. Cancer 9, 714-723 (2009).